Analytical and Clinical Validation of the Plasma-Based Guardant360 CDx Test for Assessing HER2 (ERBB2) Mutation Status in Patients with Non–Small-Cell Lung Cancer for Treatment with Trastuzumab Deruxtecan in DESTINY-Lung01/02
Titel:
Analytical and Clinical Validation of the Plasma-Based Guardant360 CDx Test for Assessing HER2 (ERBB2) Mutation Status in Patients with Non–Small-Cell Lung Cancer for Treatment with Trastuzumab Deruxtecan in DESTINY-Lung01/02
Auteur:
Qi, Zhenhao Tokuhiro, Shinya Odegaard, Justin I. Wienke, Sara Karnoub, Maha Feng, Wenqin Shiga, Ryota Smit, Egbert F. Goto, Yasushi De Langen, Adrianus J. Goto, Koichi Pereira, Kaline Khambata-Ford, Shirin
Verschenen in:
The journal of molecular diagnostics
Paginering:
Jaargang 27 () nr. 2 pagina's 119-129
Jaar:
2025
Inhoud:
Uitgever:
Association for Molecular Pathology and American Society for Investigative Pathology